posted on 2011-07-11, 10:03authored byRichard John Baines
A hallmark of progressive renal disease in man is the presence of abnormal
urinary constituents termed proteinuria. These substances include proteins, of
which albumin predominates and are derived from the serum but are present in
the urine because of abnormal glomerular permeability. Such macromolecules
are bioactive and interact with proximal tubular cells (PTC) to activate
intracellular signalling cascades. The result is a PTC phenotype that stimulates
localised renal inflammation and fibrosis whicht are characteristic pathological
changes of proteinuric nephropathy.
A PTC albumin receptor is a complex that includes megalin, a member of the
low-density lipoprotein (LDL-R) family. The paradigm regarding LDL-R family
members is that they are cargo receptors which transport ligand from one
epithelial surface to another. The cytoplasmic domains of some members of the
LDL-R mediate important signalling functions. Therefore, it is postulated that the
cytoplasmic tail of megalin (MegCT) might link PTC albumin exposure with
signalling effects within the cell. As signalling cascades and protein-protein
interactions are regulated by protein phosphorylation studies in this thesis were
designed to address whether MegCT is phosphorylated.
Potential agents of MegCT phosphorylation were used to stimulate PTC in
culture and stimulated cell lysate tested for its ability to phosphorylate a MegCTGST
fusion protein. Human serum albumin (HSA), epidermal growth factor
(EGF) and activators of Protein kinase C (PKC) were all identified to increase
the substantial basal phosphorylation of MegCT. Using specific kinase inhibitors
phosphoinositide 3-kinase (PI 3-kinase), epidermal growth factor receptor
(EGF-R) and PKC were all identified as important mediators of MegCT
phosphorylation. MegCT immunoprecipitated from intact cells demonstrated an
identical pattern of phosphorylation. To overexpress MegCT a MegCT-CD8
chimaeric protein was developed and demonstrated to associate with the cell
membrane and phosphorylate identically to MegCT-GST. Using mass
spectrometry of phosphorylated peptides derived from MegCT-GST six sites of
MegCT phosphorylation were identified under basal and stimulated conditions.
By measuring FITC-albumin uptake agents stimulating MegCT phosphorylation
were identified to be functionally associated with attenuated albumin
endocytosis.
In summary this is the first description of the regulated phosphorylation of
MegCT in PTC and indicates a number of sites of potential pharmacological
inhibition to abrogate the progression of proteinuric nephropathy.
Funding
University Hospitals of Leicester (training fellowship)